This inventor holds 1 USPTO granted patent. Top assignee: The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2004
Title: Liu Xiuhuai: Innovator in Apoptosis-Modification Technologies
Introduction
Liu Xiuhuai is a notable inventor based in Rockville, MD, USA. He has made significant contributions to the field of biotechnology, particularly in the area of apoptosis-modifying polypeptides. His work has implications for therapeutic applications in various diseases.
Latest Patents
Liu Xiuhuai holds a patent titled "Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis." This patent discloses apoptosis-modifying fusion polypeptides and the corresponding nucleic acid molecules. Additionally, it provides pharmaceutical compositions comprising these polypeptides and outlines their use in modifying apoptosis.
Career Highlights
Liu Xiuhuai is affiliated with the Government of the United States of America as represented by the Secretary of the Department of Health and Human Services. His role in this esteemed organization highlights his commitment to advancing health-related technologies.
Collaborations
Some of Liu Xiuhuai's notable coworkers include Richard J. Youle and R. John Collier. Their collaboration has likely contributed to the innovative research and development in the field of apoptosis modification.
Conclusion
Liu Xiuhuai's work in apoptosis-modifying technologies showcases his innovative spirit and dedication to improving health outcomes. His contributions through patents and collaborations continue to influence the field of biotechnology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile